Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 148 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham |
| |
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami Therapeutics develops soft mist inhaled formulations of biologics and inhalation devices to treat severe and chronic diseases. Its first product is for the treatment of diabetes. | Location Durham |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company Alcami Corporation (Durham) | Activity: Contract Research and Testing | Company Description Alcami provides contract drug and biologics development and manufacturing services, including formulation development, analytical chemistry, API, solid dose and parenteral drug manufacturing for clinical and commercial markets. Alcami's HQ is in Durham. | Location Durham |
| |
Company Alcami Corporation (Wilmington) | Activity: Production and Manufacturing | Company Description Alcami provides contract drug and biologics development and manufacturing services, including analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services. | Location Wilmington |
| |
Company Amgen | Activity: Production and Manufacturing | Company Description Amgen will manufacture therapeutics for cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The site is expected to be operational by 2025. | Location Apex |
| |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company AstraZeneca (Durham-Winchester) | Activity: Research and Development | Company Description AstraZeneca's Winchester Place site in Durham specializes in research and development across the biopharmaceuticals, vaccines and immune therapies, rare disease and oncology business units. | Location Durham |
| |
Company Basking Biosciences Inc. | Activity: Research and Development | Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. | Location Research Triangle Park |
| |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. | Location Morrisville |
| |
Company BioAgilytix Labs LLC | Activity: Contract Research and Testing | Company Description BioAgilytix is a global contract research organization and provides PK, immunogenicity, biomarkers, and cell-based assays supporting the development and release testing of therapeutics across all stages of drug development. | Location Durham |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is incubated within the Carolina BioOncology Institute. | Location Huntersville |
| |
Company Biogen | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. The Drug Substance Campus in RTP is home to biologics production and a patient services contact center. | Location Research Triangle Park |
| |
Company Catalent Pharma Solutions LLC (Morrisville) | Activity: Contract Research and Testing | Company Description Catalent provides drug development and manufacturing services for the pharma, biotech and consumer sectors. Core offerings include biologics, parenterals, oral solids, softgel, inhalation, clinical supply services and analytical services. | Location Morrisville |
| |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill |
| |
Company Cessation Therapeutics | Activity: Sales and Operations | Company Description Cessation Therapeutics is developing novel antibody therapies to prevent and reverse overdose related to fentanyl and related synthetic opioids. The Chapel Hill site is Cessation's corporate office. | Location Chapel Hill |
| |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville |
| |
Company DotBio LLC | Activity: Research and Development | Company Description DotBio develops immuno-oncology therapies. | Location Weddington |
| |
Company Dualogics LLC | Activity: Research and Development | Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. | Location Durham |
| |
Company Eisai Inc. | Activity: Sales and Operations | Company Description Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company. | Location Raleigh |
| |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham |
| |
Company Eli Lilly and Company (Durham) | Activity: Production and Manufacturing | Company Description Lilly performs drug formulation fill/finishes activities for marketed and late-stage pipeline candidates at its RTP site, with an initial focus on its diabetes products Trulicity and Tirzepatide. | Location Durham |
| |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion develops biologic and medical device technologies, such as a novel point of care in vitro diagnostic viscoelastic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham |